Neonatal Hyperbilirubinemia. Neonatal jaundice unspecified
Conditions
Interventions
Intervention 1: Intervention group: Newborns during continuous phototherapy will receive 5 mg of oral zinc sulfate twice a day. Intervention 2: Group control: Newborns only will receive continuous pho
Treatment - Drugs
Treatment - Other
Intervention group: Newborns during continuous phototherapy will receive 5 mg of oral zinc sulfate twice a day.
Group control: Newborns only will receive continuous phototherapy.
Sponsors
Vice Chancellor for Research of Lorestan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Years to 28 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Term neonates; Gestational age of 37- 41 weeks; Birth weight more than 2500 grams; The minimum and maximum age of the infants between 3 - 28 days; Total bilirubin levels of Serum between 14 - 19 mg/dl; without any sign of abnormalities and diseases (infectious, metabolic, hemolytic, glucose-six-phosphate dehydrogenase deficiency, blood group incompatibility and positive coombs test). Exclusion criteria: The need for exchange transfusion and intensive care for more than 24 hours.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total bilirubin levels of serum. Timepoint: Before intervention, 24, 48, 72 and 96 hours after intervention. Method of measurement: Measurement of serum total bilirubin (diazo method). | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of phototherapy. Timepoint: Daily. Method of measurement: Duration of phototherapy (days). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShourangiz Beiranvand
Lorestan University of Medical Sciences
Outcome results
None listed